Published in J Urol on February 01, 2006
Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogram. J Clin Oncol (2009) 3.38
Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis. Nat Rev Cancer (2010) 3.27
Cryoablation or radiofrequency ablation of the small renal mass : a meta-analysis. Cancer (2008) 2.75
Repeat partial nephrectomy on the solitary kidney: surgical, functional and oncological outcomes. J Urol (2010) 1.74
Preoperative nomogram predicting 12-year probability of metastatic renal cancer. J Urol (2008) 1.60
Natural history, growth kinetics, and outcomes of untreated clinically localized renal tumors under active surveillance. Cancer (2009) 1.60
Renal cell carcinoma. Cancer Biomark (2010) 1.56
Survival after diagnosis of localized T1a kidney cancer: current population-based practice of surgery and nonsurgical management. Urology (2013) 1.51
Understanding criteria for surveillance of patients with a small renal mass. Urology (2012) 1.48
Enhancing renal tumors in patients with prior normal abdominal imaging: further insight into the natural history of renal cell carcinoma. J Urol (2012) 1.40
Histopathological characteristics of localized renal cell carcinoma correlate with tumor size: a SEER analysis. J Urol (2008) 1.37
Metastatic renal cell carcinoma risk according to tumor size. J Urol (2009) 1.35
A novel germline mutation in BAP1 predisposes to familial clear-cell renal cell carcinoma. Mol Cancer Res (2013) 1.30
Outcomes of partial nephrectomy in patients who meet percutaneous ablation criteria. Cent European J Urol (2015) 1.19
MR classification of renal masses with pathologic correlation. Eur Radiol (2007) 1.14
Predicting growth of solid renal masses under active surveillance. Urol Oncol (2008) 1.11
Increasing detection and increasing incidence in thyroid cancer. World J Surg (2009) 1.09
Renal mass biopsy to guide treatment decisions for small incidental renal tumors: a cost-effectiveness analysis. Radiology (2010) 1.07
Tissue-based research in kidney cancer: current challenges and future directions. Clin Cancer Res (2008) 1.07
Optimal management of localized renal cell carcinoma: surgery, ablation, or active surveillance. J Natl Compr Canc Netw (2009) 1.05
Diagnostic accuracy and clinical impact of imaging-guided needle biopsy of renal masses. Retrospective analysis on 150 cases. Eur Radiol (2010) 1.02
Small renal masses: incidental diagnosis, clinical symptoms, and prognostic factors. Adv Urol (2009) 1.00
Growth pattern of renal cell carcinoma (RCC) in patients with delayed surgical intervention. J Cancer Res Clin Oncol (2011) 0.97
Volume doubling time and growth rate of renal cell carcinoma determined by helical CT: a single-institution experience. Eur Radiol (2007) 0.95
Active surveillance for small renal masses. Rev Urol (2012) 0.95
Short-term change in growth of uterine leiomyoma: tumor growth spurts. Fertil Steril (2010) 0.93
Access, excess, and overdiagnosis: the case for thyroid cancer. Cancer Med (2014) 0.91
Pathologic concordance of sporadic synchronous bilateral renal masses. Urology (2008) 0.90
Solid renal masses: what the numbers tell us. AJR Am J Roentgenol (2014) 0.90
Review of renal cell carcinoma and its common subtypes in radiology. World J Radiol (2016) 0.89
Growth kinetics and short-term outcomes of cT1b and cT2 renal masses under active surveillance. J Urol (2014) 0.89
Tumor doubling time of renal cell carcinoma measured by CT. Indian J Urol (2014) 0.88
MRI phenotype in renal cancer: is it clinically relevant? Top Magn Reson Imaging (2014) 0.86
Assessment and characterisation of common renal masses with CT and MRI. Insights Imaging (2011) 0.86
Active surveillance of small renal masses. Nat Rev Urol (2013) 0.86
Small renal masses: surgery or surveillance. Korean J Urol (2013) 0.85
Effectiveness and safety of computed tomography-guided radiofrequency ablation of renal cancer: a 14-year single institution experience in 203 patients. Eur Radiol (2015) 0.84
Impact of the length of time between diagnosis and surgical removal of urologic neoplasms on survival. World J Urol (2013) 0.83
3D cone-beam CT guidance, a novel technique in renal biopsy--results in 41 patients with suspected renal masses. Eur Radiol (2012) 0.83
To biopsy a small renal mass, or not? Nephrourol Mon (2012) 0.83
Active surveillance of renal masses in von Hippel-Lindau disease: growth rates and clinical outcome over a median follow-up period of 56 months. Fam Cancer (2012) 0.83
The natural history and predictors for intervention in patients with small renal mass undergoing active surveillance. Adv Urol (2015) 0.82
Is tumor size a reliable predictor of histopathological characteristics of renal cell carcinoma? Urol Ann (2012) 0.81
Renal transplantation with kidneys affected by tumours. Int J Nephrol (2011) 0.81
The contemporary role of renal mass biopsy in the management of small renal tumors. Front Oncol (2012) 0.81
Challenging treatment decision-making in older urologic cancer patients. World J Urol (2013) 0.81
Imaging and management of the incidentally discovered renal mass. Cancer Imaging (2009) 0.80
Management of small renal masses: a review. World J Urol (2010) 0.80
Predicting factors for death from other causes in patients with localized renal cell carcinoma. Korean J Urol (2012) 0.80
Histological characterisation of small renal masses and incidence of silent renal masses. Adv Urol (2008) 0.80
Current status of renal biopsy for small renal masses. Korean J Urol (2014) 0.80
Active surveillance as the preferred management option for small renal masses. Can Urol Assoc J (2010) 0.80
Pathological characteristics and radiographic correlates of complex renal cysts. Urol Oncol (2014) 0.79
Are multiple cryoprobes additive or synergistic in renal cryotherapy? Urology (2011) 0.79
Focal therapy for kidney cancer: a systematic review. Curr Opin Urol (2009) 0.79
The role of radiologic imaging and biopsy in renal tumor ablation. World J Urol (2010) 0.79
Surveillance as an option for the treatment of small renal masses. Adv Urol (2008) 0.79
Renal preservation therapy for renal cell carcinoma. Int J Surg Oncol (2012) 0.78
The evolving management of small renal masses. Curr Oncol Rep (2009) 0.78
Renal Cell Carcinoma Update: News from the AUA, EAU, and ASCO Annual Meetings 2011. ISRN Urol (2012) 0.78
Evaluation of percutaneous biopsies of renal masses under MRI-guidance: a retrospective study about 26 cases. Eur Radiol (2014) 0.78
Kidney cancer in 2010: drugs, surgery and survival in RCC. Nat Rev Urol (2011) 0.78
External validation of the RENAL nephrometry score nomogram for predicting high-grade renal cell carcinoma in solid, enhancing, and small renal masses. World J Urol (2013) 0.78
Review of the efficacy and safety of radiofrequency ablation for the treatment of small renal masses. Can Urol Assoc J (2009) 0.78
Natural history of small renal masses. Chin Med J (Engl) (2015) 0.78
Experience of ultrasonography-guided percutaneous core biopsy for renal masses. Korean J Urol (2013) 0.77
Kidney cancer in 2011: objectifying risk for localized renal masses. Nat Rev Urol (2011) 0.77
Optimal freeze cycle length for renal cryotherapy. J Urol (2011) 0.77
Imaging of Solid Renal Masses. Radiol Clin North Am (2016) 0.77
Is anatomic complexity associated with renal tumor growth kinetics under active surveillance? Urol Oncol (2015) 0.77
Growth Pattern of Clear Cell Renal Cell Carcinoma in Patients with Delayed Surgical Intervention: Fast Growth Rate Correlates with High Grade and May Result in Poor Prognosis. Biomed Res Int (2015) 0.77
Clinical outcome of incidentally discovered small renal cell carcinoma after delayed surgery. Cancer Manag Res (2013) 0.77
Watchful waiting in the treatment of the small renal mass. Indian J Urol (2009) 0.76
Thermoablation of Renal Masses: The Urologist's Perspective. Semin Intervent Radiol (2011) 0.76
Efficacy of laparoscopic renal cryoablation as an alternative treatment for small renal mass in patients with poor operability: experience from the Korean single center. J Laparoendosc Adv Surg Tech A (2010) 0.76
Thinking beyond surgery in the management of renal cell carcinoma: the risk to die from renal cell carcinoma and competing risks of death. World J Urol (2014) 0.76
Optimal management of renal cell carcinoma in the elderly: a review. Clin Interv Aging (2013) 0.75
Preferred management option for small renal masses: laparoscopic partial nephrectomy. Can Urol Assoc J (2010) 0.75
Multi-Point Thermal Sensors Associated with Improved Oncological Outcomes Following Cryoablation. J Endourol (2017) 0.75
Robotic nephron-sparing surgery for renal tumors: Current status. Indian J Urol (2014) 0.75
Stereotactic Ablative Radiotherapy for the Treatment of Clinically Localized Renal Cell Carcinoma. J Oncol (2015) 0.75
Should small renal masses be managed expectantly? Indian J Urol (2007) 0.75
The changing scenario of nephron sparing approaches to treat renal tumors: Making a case to save the nephrons! Indian J Urol (2009) 0.75
Renal Tumor Biopsy Technique. Chin Med J (Engl) (2016) 0.75
Recent developments in kidney cancer. Can Urol Assoc J (2011) 0.75
Ongoing debate on the management of small renal masses: should they be treated like low-risk prostate cancers? Korean J Urol (2013) 0.75
The changing face of renal-cell carcinoma. J Endourol (2010) 0.75
A proposal for a targeted screening program for renal cancer. Front Oncol (2013) 0.75
The effect of delaying nephrectomy on oncologic outcomes in patients with renal tumors greater than 4cm. Urol Oncol (2016) 0.75
Kidney cancer: first guidelines for unilateral cT1 renal tumor management. Nat Rev Urol (2010) 0.75
Clinical Outcome of Small Renal Cell Carcinoma after Delayed Surgery versus Immediate Surgery. J Cancer (2013) 0.75
Non-Surgical Ablative Therapy for Management of Small Renal Masses-Current Status and Future Trends. Indian J Surg Oncol (2016) 0.75
Progression to metastatic disease from a small renal cell carcinoma prospectively followed with an active surveillance protocol. Can Urol Assoc J (2007) 0.75
The contemporary role of surgery in kidney cancer. Curr Oncol (2009) 0.75
Whole lesion quantitative CT evaluation of renal cell carcinoma: differentiation of clear cell from papillary renal cell carcinoma. Springerplus (2015) 0.75
Bilateral benign renal oncocytomas and the role of renal biopsy: single institution review. BMC Urol (2017) 0.75
Can the R.e.N.a.L nephrometry score preoperatively predict postoperative clinical outcomes in patients undergoing open and laparoscopic partial nephrectomy? Curr Urol (2013) 0.75
Natural history and management of small renal masses. Curr Oncol (2009) 0.75
Small Incidental Renal Masses in Adults: Review of the literature. Sultan Qaboos Univ Med J (2010) 0.75
Surveillance for the management of small renal masses. Adv Urol (2008) 0.75
Guideline for management of the clinical T1 renal mass. J Urol (2009) 8.26
The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth. J Urol (2009) 6.71
Randomized trial of hypofractionated external-beam radiotherapy for prostate cancer. J Clin Oncol (2013) 4.78
Excise, ablate or observe: the small renal mass dilemma--a meta-analysis and review. J Urol (2008) 3.46
Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogram. J Clin Oncol (2009) 3.38
Accuracy of determining nodal negativity in colorectal cancer on the basis of the number of nodes retrieved on resection. Ann Surg Oncol (2003) 3.27
What dose of external-beam radiation is high enough for prostate cancer? Int J Radiat Oncol Biol Phys (2007) 3.24
Trends in radical prostatectomy: centralization, robotics, and access to urologic cancer care. Cancer (2011) 3.13
Histological subtype is an independent predictor of outcome for patients with renal cell carcinoma. J Urol (2010) 3.06
Positron emission tomography/computed tomography identification of clear cell renal cell carcinoma: results from the REDECT trial. J Clin Oncol (2012) 3.03
Cutaneous metastases from genitourinary malignancies. Urology (2004) 2.97
Objective measures of renal mass anatomic complexity predict rates of major complications following partial nephrectomy. Eur Urol (2011) 2.87
Cryoablation or radiofrequency ablation of the small renal mass : a meta-analysis. Cancer (2008) 2.75
The impact of positive surgical margins on mortality following radical prostatectomy during the prostate specific antigen era. J Urol (2010) 2.60
Academic ranking score: a publication-based reproducible metric of thought leadership in urology. Eur Urol (2011) 2.51
CPAP, weight loss, or both for obstructive sleep apnea. N Engl J Med (2014) 2.50
Bladder cancer. J Natl Compr Canc Netw (2013) 2.46
Treatment of patients with small renal masses: a survey of the American Urological Association. J Urol (2010) 2.45
The impact of temporal presentation on clinical and pathological outcomes for patients with sporadic bilateral renal masses. Eur Urol (2008) 2.40
Radiation therapy after radical prostatectomy: impact on metastasis and survival. J Urol (2009) 2.37
Hypoxic prostate/muscle PO2 ratio predicts for outcome in patients with localized prostate cancer: long-term results. Int J Radiat Oncol Biol Phys (2011) 2.23
Anatomic features of enhancing renal masses predict malignant and high-grade pathology: a preoperative nomogram using the RENAL Nephrometry score. Eur Urol (2011) 2.22
Prevalence of baseline chronic kidney disease in patients presenting with solid renal tumors. Urology (2011) 2.20
Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial. Int J Radiat Oncol Biol Phys (2005) 2.08
Promoter hypermethylation profile of kidney cancer. Clin Cancer Res (2004) 2.02
Small renal masses progressing to metastases under active surveillance: a systematic review and pooled analysis. Cancer (2011) 1.98
The Phoenix definition of biochemical failure predicts for overall survival in patients with prostate cancer. Cancer (2008) 1.98
Rationale for percutaneous biopsy and histologic characterisation of renal tumours. Eur Urol (2012) 1.95
Outcome of stage T2 or greater renal cell cancer treated with partial nephrectomy. J Urol (2010) 1.93
Practice-setting and surgeon characteristics heavily influence the decision to perform partial nephrectomy among American Urologic Association surgeons. BJU Int (2012) 1.87
Urinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carcinoma. BJU Int (2011) 1.78
Lymphopenia is an independent predictor of inferior outcome in clear cell renal carcinoma. J Urol (2012) 1.78
Baseline renal function status limits patient eligibility to receive perioperative chemotherapy for invasive bladder cancer and is minimally affected by radical cystectomy. Urology (2010) 1.77
The expanding role of partial nephrectomy: a critical analysis of indications, results, and complications. Eur Urol (2009) 1.70
Delayed intervention of sporadic renal masses undergoing active surveillance. Cancer (2008) 1.64
Trends in regionalization of adrenalectomy to higher volume surgical centers. J Urol (2012) 1.64
Natural history, growth kinetics, and outcomes of untreated clinically localized renal tumors under active surveillance. Cancer (2009) 1.60
Enhancing renal masses with zero net growth during active surveillance. J Urol (2007) 1.59
T-cell coregulatory molecule expression in urothelial cell carcinoma: clinicopathologic correlations and association with survival. Clin Cancer Res (2008) 1.58
Role of prostate dose escalation in patients with greater than 15% risk of pelvic lymph node involvement. Int J Radiat Oncol Biol Phys (2005) 1.57
Interval to biochemical failure highly prognostic for distant metastasis and prostate cancer-specific mortality after radiotherapy. Int J Radiat Oncol Biol Phys (2007) 1.55
Assessing performance trends in laparoscopic nephrectomy and nephron-sparing surgery for localized renal tumors. Urology (2012) 1.54
Identification of novel target genes by an epigenetic reactivation screen of renal cancer. Cancer Res (2006) 1.49
Clinical characteristics associated with treatment type for localized renal tumors: implications for practice pattern assessment. Urology (2013) 1.49
Decision-making strategies for patients with localized prostate cancer. Semin Urol Oncol (2002) 1.48
Nephron-sparing management vs radical nephroureterectomy for low- or moderate-grade, low-stage upper tract urothelial carcinoma. BJU Int (2014) 1.47
Dose response in prostate cancer with 8-12 years' follow-up. Int J Radiat Oncol Biol Phys (2002) 1.46
Utility of the R.E.N.A.L. nephrometry scoring system in objectifying treatment decision-making of the enhancing renal mass. Urology (2011) 1.46
Do percutaneous renal tumor biopsies at initial presentation affect treatment strategies? Eur Urol (2008) 1.45
Robot-assisted partial nephrectomy: a large single-institutional experience. Urology (2010) 1.45
Role of tumor location in selecting patients for percutaneous versus surgical cryoablation of renal masses. Can J Urol (2012) 1.45
Intensity modulated radiation therapy (IMRT) decreases acute skin toxicity for women receiving radiation for breast cancer. Am J Clin Oncol (2006) 1.45
Preoperative hydronephrosis, ureteroscopic biopsy grade and urinary cytology can improve prediction of advanced upper tract urothelial carcinoma. J Urol (2010) 1.44
Comparison of prostate cancer diagnosis in patients receiving unrelated urological and non-urological cancer care. BJU Int (2013) 1.41
Why Summary Comorbidity Measures Such As the Charlson Comorbidity Index and Elixhauser Score Work. Med Care (2015) 1.41
Enhancing renal tumors in patients with prior normal abdominal imaging: further insight into the natural history of renal cell carcinoma. J Urol (2012) 1.40
The need for androgen deprivation therapy in patients with intermediate-risk prostate cancer treated with dose-escalated external beam radiation therapy. Can J Urol (2017) 1.39
How Hugh Hampton Young's treatment of President Woodrow Wilson's urinary retention and urosepsis affected the resolution of World War I. J Urol (2011) 1.38
The relationship of increasing radiotherapy dose to reduced distant metastases and mortality in men with prostate cancer. Cancer (2004) 1.38
Temporal relationship between positive margin rate after laparoscopic radical prostatectomy and surgical training. Urology (2010) 1.38
Histopathological characteristics of localized renal cell carcinoma correlate with tumor size: a SEER analysis. J Urol (2008) 1.37